Voyager Therapeutics's total assets for Q1 2026 were $219.32M, a decrease of -13.06% from the previous quarter. VYGR total liabilities were $45.66M for the fiscal quarter, a -18.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.